3 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 3 |
Follow Cellulitis: new trials by email Literature Review of Cellulitis trials Research Report on Cellulitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hospital Avoidance Strategies for ABSSSI Dalbavancin - Skin Infection | Phase 4 | Terminated | Washington University School of Medicine | 11 | 2019-03-04 | 2022-12-09 |
| Duration of ANtibiotic Therapy for CEllulitis Flucloxacillin, Placebo (for flucloxacillin) - Cellulitis, Erysipelas | Phase 4 | Terminated | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 151 | 2014-08-26 | 2017-10-10 |
| Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections Daptomycin - Staphylococcal Skin Infections | Phase 4 | Terminated | Novartis | 52 | 2007-01-01 | 2011-03-24 |
Abscess (1) · Diabetic Foot (1) · Emergencies (1) · Erysipelas (1) · Staphylococcal Skin Infections (1)
Connective Tissue Diseases (3) · Infections (3) · Inflammation (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Skin Diseases, Infectious (3) · Skin and Connective Tissue Diseases (3) · Suppuration (3) · Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Gram-Positive Bacterial Infections (2) · Skin Diseases (2) · Skin Diseases, Bacterial (2) · Cardiovascular Diseases (1) · Diabetes Complications (1)
Daptomycin (1) · Floxacillin (1) · dalbavancin (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Novartis (1) · Washington University School of Medicine (1)
Italy (1) · Netherlands (1) · United States (1)
Jan M. Prins, MD, PhD (1) · Stephen Y Liang, MD (1) · W. Joost Wiersinga, MD, PhD (1)